Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)
Given the prominent role of anxiety in PTSD and specific requirement for NO to generalize extinction of fear learning to novel contexts (Sadeghi et al., 2022), PTSD is a particularly promising candidate for therapeutic NOS inhibition
These complexes work sequentially to transfer electrons, establish a proton gradient, and drive ATP synthesis
However, no matter the source, youre accumulating more than your body can excrete in urine and stool
Hair shedding driven by B12 deficiency is typically a form of telogen effluvium (stress-related shedding) and responds well to repletion
